G. Van Genechten
Publications by Year
Research Areas
Atrial Fibrillation Management and Outcomes, Antiplatelet Therapy and Cardiovascular Diseases, Health Systems, Economic Evaluations, Quality of Life, Cardiovascular Function and Risk Factors, Cardiac Arrhythmias and Treatments
Most-Cited Works
- → Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries(2019)354 cited
- → Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event(2020)80 cited
- → Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease—A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V(2020)79 cited
- → Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry(2022)66 cited
- → Epidemiology and impact of frailty in patients with atrial fibrillation in Europe(2022)60 cited
- → Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry(2021)52 cited
- → Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Registry(2021)29 cited
- → Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry(2022)17 cited
- → Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry(2022)14 cited
- → Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry(2022)5 cited